^
HercepTest is a semi-quantitative immunohistochemical assay for determination of HER2 protein (c-erbB-2 oncoprotein) overexpression in breast cancer tissues routinely processed for histological evaluation and formalin-fixed, paraffin-embedded cancer tissue from patients with adenocarcinoma of the stomach, including the gastroesophageal junction. HercepTest specifically demonstrates overexpression of HER2 protein. HercepTest is indicated as an aid in the assessment of patients for whom Herceptin™ (trastuzumab) treatment is being considered.
Cancer:
Breast Cancer, Gastric Cancer, Gastroesophageal Cancer
Gene:
HER-2 (Human epidermal growth factor receptor 2)
Drug:
Herceptin (trastuzumab), Kadcyla (ado-trastuzumab emtansine), Perjeta (pertuzumab)
Method:
Immunohistochemistry (IHC)
Approvals
Date
Cancer
Gene
Drug
By